1. Home
  2. SNES vs TNON Comparison

SNES vs TNON Comparison

Compare SNES & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SenesTech Inc.

SNES

SenesTech Inc.

HOLD

Current Price

$1.89

Market Cap

12.1M

Sector

Industrials

ML Signal

HOLD

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.80

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNES
TNON
Founded
2004
2012
Country
United States
United States
Employees
N/A
27
Industry
Agricultural Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
9.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
SNES
TNON
Price
$1.89
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
47.6K
138.6K
Earning Date
06-19-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
77.99
N/A
EPS
N/A
N/A
Revenue
$600,000.00
N/A
Revenue This Year
$41.52
$19.56
Revenue Next Year
$77.28
$71.06
P/E Ratio
N/A
N/A
Revenue Growth
132.56
N/A
52 Week Low
$1.30
$0.64
52 Week High
$5.99
$5.85

Technical Indicators

Market Signals
Indicator
SNES
TNON
Relative Strength Index (RSI) 41.39 46.44
Support Level $1.65 $0.72
Resistance Level $2.26 $0.89
Average True Range (ATR) 0.18 0.05
MACD -0.02 0.01
Stochastic Oscillator 7.14 45.43

Price Performance

Historical Comparison
SNES
TNON

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Share on Social Networks: